nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC47A1—Mitoxantrone—breast cancer	0.333	0.609	CbGbCtD
Famotidine—SLC22A2—Vinblastine—breast cancer	0.072	0.132	CbGbCtD
Famotidine—CYP2C19—Lapatinib—breast cancer	0.0695	0.127	CbGbCtD
Famotidine—SLC22A8—Methotrexate—breast cancer	0.0368	0.0674	CbGbCtD
Famotidine—CYP2C19—Tamoxifen—breast cancer	0.0348	0.0638	CbGbCtD
Famotidine—Confusional state—Capecitabine—breast cancer	0.000106	0.000301	CcSEcCtD
Famotidine—Feeling abnormal—Paclitaxel—breast cancer	0.000105	0.0003	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000105	0.000299	CcSEcCtD
Famotidine—Oedema—Capecitabine—breast cancer	0.000105	0.000299	CcSEcCtD
Famotidine—Bradycardia—Epirubicin—breast cancer	0.000105	0.000298	CcSEcCtD
Famotidine—Gastrointestinal pain—Paclitaxel—breast cancer	0.000105	0.000298	CcSEcCtD
Famotidine—Diarrhoea—Gemcitabine—breast cancer	0.000104	0.000297	CcSEcCtD
Famotidine—Infection—Capecitabine—breast cancer	0.000104	0.000297	CcSEcCtD
Famotidine—Erythema multiforme—Methotrexate—breast cancer	0.000104	0.000296	CcSEcCtD
Famotidine—Dizziness—Irinotecan—breast cancer	0.000104	0.000295	CcSEcCtD
Famotidine—Jaundice—Doxorubicin—breast cancer	0.000103	0.000294	CcSEcCtD
Famotidine—Anorexia—Docetaxel—breast cancer	0.000103	0.000294	CcSEcCtD
Famotidine—Shock—Capecitabine—breast cancer	0.000103	0.000294	CcSEcCtD
Famotidine—Hepatitis—Epirubicin—breast cancer	0.000103	0.000293	CcSEcCtD
Famotidine—Diarrhoea—Fluorouracil—breast cancer	0.000103	0.000292	CcSEcCtD
Famotidine—Thrombocytopenia—Capecitabine—breast cancer	0.000103	0.000292	CcSEcCtD
Famotidine—Tinnitus—Methotrexate—breast cancer	0.000103	0.000292	CcSEcCtD
Famotidine—Pharyngitis—Epirubicin—breast cancer	0.000102	0.000291	CcSEcCtD
Famotidine—Urticaria—Paclitaxel—breast cancer	0.000102	0.000289	CcSEcCtD
Famotidine—Haematuria—Doxorubicin—breast cancer	0.000101	0.000288	CcSEcCtD
Famotidine—Abdominal pain—Paclitaxel—breast cancer	0.000101	0.000288	CcSEcCtD
Famotidine—Body temperature increased—Paclitaxel—breast cancer	0.000101	0.000288	CcSEcCtD
Famotidine—Anorexia—Capecitabine—breast cancer	0.0001	0.000285	CcSEcCtD
Famotidine—Vomiting—Mitoxantrone—breast cancer	9.97e-05	0.000284	CcSEcCtD
Famotidine—Vomiting—Irinotecan—breast cancer	9.97e-05	0.000284	CcSEcCtD
Famotidine—Sinusitis—Doxorubicin—breast cancer	9.95e-05	0.000283	CcSEcCtD
Famotidine—Dizziness—Fluorouracil—breast cancer	9.93e-05	0.000283	CcSEcCtD
Famotidine—Agranulocytosis—Doxorubicin—breast cancer	9.9e-05	0.000282	CcSEcCtD
Famotidine—Rash—Irinotecan—breast cancer	9.88e-05	0.000281	CcSEcCtD
Famotidine—Rash—Mitoxantrone—breast cancer	9.88e-05	0.000281	CcSEcCtD
Famotidine—Dermatitis—Mitoxantrone—breast cancer	9.88e-05	0.000281	CcSEcCtD
Famotidine—Dermatitis—Irinotecan—breast cancer	9.88e-05	0.000281	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Docetaxel—breast cancer	9.87e-05	0.000281	CcSEcCtD
Famotidine—Headache—Irinotecan—breast cancer	9.82e-05	0.00028	CcSEcCtD
Famotidine—Headache—Mitoxantrone—breast cancer	9.82e-05	0.00028	CcSEcCtD
Famotidine—Insomnia—Docetaxel—breast cancer	9.8e-05	0.000279	CcSEcCtD
Famotidine—Paraesthesia—Docetaxel—breast cancer	9.73e-05	0.000277	CcSEcCtD
Famotidine—Erythema multiforme—Epirubicin—breast cancer	9.73e-05	0.000277	CcSEcCtD
Famotidine—Alopecia—Methotrexate—breast cancer	9.72e-05	0.000277	CcSEcCtD
Famotidine—Vomiting—Gemcitabine—breast cancer	9.71e-05	0.000276	CcSEcCtD
Famotidine—Bradycardia—Doxorubicin—breast cancer	9.69e-05	0.000276	CcSEcCtD
Famotidine—Somnolence—Docetaxel—breast cancer	9.63e-05	0.000274	CcSEcCtD
Famotidine—Mental disorder—Methotrexate—breast cancer	9.63e-05	0.000274	CcSEcCtD
Famotidine—Rash—Gemcitabine—breast cancer	9.63e-05	0.000274	CcSEcCtD
Famotidine—Dermatitis—Gemcitabine—breast cancer	9.62e-05	0.000274	CcSEcCtD
Famotidine—Tinnitus—Epirubicin—breast cancer	9.59e-05	0.000273	CcSEcCtD
Famotidine—Headache—Gemcitabine—breast cancer	9.57e-05	0.000272	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Capecitabine—breast cancer	9.56e-05	0.000272	CcSEcCtD
Famotidine—Flushing—Epirubicin—breast cancer	9.55e-05	0.000272	CcSEcCtD
Famotidine—Vomiting—Fluorouracil—breast cancer	9.55e-05	0.000272	CcSEcCtD
Famotidine—Dyspepsia—Docetaxel—breast cancer	9.54e-05	0.000272	CcSEcCtD
Famotidine—Hepatitis—Doxorubicin—breast cancer	9.52e-05	0.000271	CcSEcCtD
Famotidine—Insomnia—Capecitabine—breast cancer	9.49e-05	0.00027	CcSEcCtD
Famotidine—Rash—Fluorouracil—breast cancer	9.47e-05	0.000269	CcSEcCtD
Famotidine—Dermatitis—Fluorouracil—breast cancer	9.46e-05	0.000269	CcSEcCtD
Famotidine—Pharyngitis—Doxorubicin—breast cancer	9.45e-05	0.000269	CcSEcCtD
Famotidine—Paraesthesia—Capecitabine—breast cancer	9.42e-05	0.000268	CcSEcCtD
Famotidine—Decreased appetite—Docetaxel—breast cancer	9.42e-05	0.000268	CcSEcCtD
Famotidine—Hypersensitivity—Paclitaxel—breast cancer	9.42e-05	0.000268	CcSEcCtD
Famotidine—Headache—Fluorouracil—breast cancer	9.41e-05	0.000268	CcSEcCtD
Famotidine—Dysgeusia—Methotrexate—breast cancer	9.37e-05	0.000267	CcSEcCtD
Famotidine—Fatigue—Docetaxel—breast cancer	9.34e-05	0.000266	CcSEcCtD
Famotidine—Nausea—Mitoxantrone—breast cancer	9.31e-05	0.000265	CcSEcCtD
Famotidine—Nausea—Irinotecan—breast cancer	9.31e-05	0.000265	CcSEcCtD
Famotidine—Pain—Docetaxel—breast cancer	9.27e-05	0.000264	CcSEcCtD
Famotidine—Constipation—Docetaxel—breast cancer	9.27e-05	0.000264	CcSEcCtD
Famotidine—Back pain—Methotrexate—breast cancer	9.26e-05	0.000264	CcSEcCtD
Famotidine—Dyspepsia—Capecitabine—breast cancer	9.24e-05	0.000263	CcSEcCtD
Famotidine—Arrhythmia—Epirubicin—breast cancer	9.19e-05	0.000262	CcSEcCtD
Famotidine—Asthenia—Paclitaxel—breast cancer	9.17e-05	0.000261	CcSEcCtD
Famotidine—Decreased appetite—Capecitabine—breast cancer	9.12e-05	0.00026	CcSEcCtD
Famotidine—Alopecia—Epirubicin—breast cancer	9.09e-05	0.000259	CcSEcCtD
Famotidine—Nausea—Gemcitabine—breast cancer	9.07e-05	0.000258	CcSEcCtD
Famotidine—Fatigue—Capecitabine—breast cancer	9.05e-05	0.000257	CcSEcCtD
Famotidine—Pruritus—Paclitaxel—breast cancer	9.05e-05	0.000257	CcSEcCtD
Famotidine—Mental disorder—Epirubicin—breast cancer	9.01e-05	0.000257	CcSEcCtD
Famotidine—Erythema multiforme—Doxorubicin—breast cancer	9e-05	0.000256	CcSEcCtD
Famotidine—Pain—Capecitabine—breast cancer	8.97e-05	0.000255	CcSEcCtD
Famotidine—Constipation—Capecitabine—breast cancer	8.97e-05	0.000255	CcSEcCtD
Famotidine—Feeling abnormal—Docetaxel—breast cancer	8.93e-05	0.000254	CcSEcCtD
Famotidine—Nausea—Fluorouracil—breast cancer	8.92e-05	0.000254	CcSEcCtD
Famotidine—Tinnitus—Doxorubicin—breast cancer	8.88e-05	0.000253	CcSEcCtD
Famotidine—Gastrointestinal pain—Docetaxel—breast cancer	8.86e-05	0.000252	CcSEcCtD
Famotidine—Anaemia—Methotrexate—breast cancer	8.85e-05	0.000252	CcSEcCtD
Famotidine—Flushing—Doxorubicin—breast cancer	8.84e-05	0.000251	CcSEcCtD
Famotidine—Dysgeusia—Epirubicin—breast cancer	8.77e-05	0.00025	CcSEcCtD
Famotidine—Diarrhoea—Paclitaxel—breast cancer	8.75e-05	0.000249	CcSEcCtD
Famotidine—Back pain—Epirubicin—breast cancer	8.66e-05	0.000247	CcSEcCtD
Famotidine—Feeling abnormal—Capecitabine—breast cancer	8.65e-05	0.000246	CcSEcCtD
Famotidine—Muscle spasms—Epirubicin—breast cancer	8.61e-05	0.000245	CcSEcCtD
Famotidine—Gastrointestinal pain—Capecitabine—breast cancer	8.58e-05	0.000244	CcSEcCtD
Famotidine—Abdominal pain—Docetaxel—breast cancer	8.57e-05	0.000244	CcSEcCtD
Famotidine—Body temperature increased—Docetaxel—breast cancer	8.57e-05	0.000244	CcSEcCtD
Famotidine—Leukopenia—Methotrexate—breast cancer	8.57e-05	0.000244	CcSEcCtD
Famotidine—Arrhythmia—Doxorubicin—breast cancer	8.5e-05	0.000242	CcSEcCtD
Famotidine—Dizziness—Paclitaxel—breast cancer	8.46e-05	0.000241	CcSEcCtD
Famotidine—Alopecia—Doxorubicin—breast cancer	8.41e-05	0.000239	CcSEcCtD
Famotidine—Cough—Methotrexate—breast cancer	8.35e-05	0.000238	CcSEcCtD
Famotidine—Mental disorder—Doxorubicin—breast cancer	8.34e-05	0.000237	CcSEcCtD
Famotidine—Urticaria—Capecitabine—breast cancer	8.34e-05	0.000237	CcSEcCtD
Famotidine—Abdominal pain—Capecitabine—breast cancer	8.29e-05	0.000236	CcSEcCtD
Famotidine—Body temperature increased—Capecitabine—breast cancer	8.29e-05	0.000236	CcSEcCtD
Famotidine—Convulsion—Methotrexate—breast cancer	8.29e-05	0.000236	CcSEcCtD
Famotidine—Anaemia—Epirubicin—breast cancer	8.28e-05	0.000236	CcSEcCtD
Famotidine—Agitation—Epirubicin—breast cancer	8.23e-05	0.000234	CcSEcCtD
Famotidine—Myalgia—Methotrexate—breast cancer	8.15e-05	0.000232	CcSEcCtD
Famotidine—Arthralgia—Methotrexate—breast cancer	8.15e-05	0.000232	CcSEcCtD
Famotidine—Chest pain—Methotrexate—breast cancer	8.15e-05	0.000232	CcSEcCtD
Famotidine—Vomiting—Paclitaxel—breast cancer	8.13e-05	0.000231	CcSEcCtD
Famotidine—Dysgeusia—Doxorubicin—breast cancer	8.12e-05	0.000231	CcSEcCtD
Famotidine—Rash—Paclitaxel—breast cancer	8.06e-05	0.000229	CcSEcCtD
Famotidine—Dermatitis—Paclitaxel—breast cancer	8.05e-05	0.000229	CcSEcCtD
Famotidine—Syncope—Epirubicin—breast cancer	8.03e-05	0.000229	CcSEcCtD
Famotidine—Leukopenia—Epirubicin—breast cancer	8.02e-05	0.000228	CcSEcCtD
Famotidine—Back pain—Doxorubicin—breast cancer	8.02e-05	0.000228	CcSEcCtD
Famotidine—Headache—Paclitaxel—breast cancer	8.01e-05	0.000228	CcSEcCtD
Famotidine—Hypersensitivity—Docetaxel—breast cancer	7.98e-05	0.000227	CcSEcCtD
Famotidine—Muscle spasms—Doxorubicin—breast cancer	7.97e-05	0.000227	CcSEcCtD
Famotidine—Palpitations—Epirubicin—breast cancer	7.92e-05	0.000225	CcSEcCtD
Famotidine—Confusional state—Methotrexate—breast cancer	7.88e-05	0.000224	CcSEcCtD
Famotidine—Loss of consciousness—Epirubicin—breast cancer	7.87e-05	0.000224	CcSEcCtD
Famotidine—Cough—Epirubicin—breast cancer	7.82e-05	0.000222	CcSEcCtD
Famotidine—Anaphylactic shock—Methotrexate—breast cancer	7.81e-05	0.000222	CcSEcCtD
Famotidine—Asthenia—Docetaxel—breast cancer	7.78e-05	0.000221	CcSEcCtD
Famotidine—Convulsion—Epirubicin—breast cancer	7.76e-05	0.000221	CcSEcCtD
Famotidine—Infection—Methotrexate—breast cancer	7.76e-05	0.000221	CcSEcCtD
Famotidine—Hypersensitivity—Capecitabine—breast cancer	7.73e-05	0.00022	CcSEcCtD
Famotidine—Pruritus—Docetaxel—breast cancer	7.67e-05	0.000218	CcSEcCtD
Famotidine—Anaemia—Doxorubicin—breast cancer	7.66e-05	0.000218	CcSEcCtD
Famotidine—Thrombocytopenia—Methotrexate—breast cancer	7.65e-05	0.000218	CcSEcCtD
Famotidine—Chest pain—Epirubicin—breast cancer	7.63e-05	0.000217	CcSEcCtD
Famotidine—Myalgia—Epirubicin—breast cancer	7.63e-05	0.000217	CcSEcCtD
Famotidine—Arthralgia—Epirubicin—breast cancer	7.63e-05	0.000217	CcSEcCtD
Famotidine—Agitation—Doxorubicin—breast cancer	7.62e-05	0.000217	CcSEcCtD
Famotidine—Anxiety—Epirubicin—breast cancer	7.6e-05	0.000216	CcSEcCtD
Famotidine—Nausea—Paclitaxel—breast cancer	7.59e-05	0.000216	CcSEcCtD
Famotidine—Asthenia—Capecitabine—breast cancer	7.53e-05	0.000214	CcSEcCtD
Famotidine—Dry mouth—Epirubicin—breast cancer	7.46e-05	0.000212	CcSEcCtD
Famotidine—Anorexia—Methotrexate—breast cancer	7.45e-05	0.000212	CcSEcCtD
Famotidine—Syncope—Doxorubicin—breast cancer	7.43e-05	0.000212	CcSEcCtD
Famotidine—Pruritus—Capecitabine—breast cancer	7.42e-05	0.000211	CcSEcCtD
Famotidine—Leukopenia—Doxorubicin—breast cancer	7.42e-05	0.000211	CcSEcCtD
Famotidine—Diarrhoea—Docetaxel—breast cancer	7.42e-05	0.000211	CcSEcCtD
Famotidine—Confusional state—Epirubicin—breast cancer	7.37e-05	0.00021	CcSEcCtD
Famotidine—Palpitations—Doxorubicin—breast cancer	7.32e-05	0.000208	CcSEcCtD
Famotidine—Anaphylactic shock—Epirubicin—breast cancer	7.31e-05	0.000208	CcSEcCtD
Famotidine—Oedema—Epirubicin—breast cancer	7.31e-05	0.000208	CcSEcCtD
Famotidine—Loss of consciousness—Doxorubicin—breast cancer	7.28e-05	0.000207	CcSEcCtD
Famotidine—Infection—Epirubicin—breast cancer	7.26e-05	0.000207	CcSEcCtD
Famotidine—Cough—Doxorubicin—breast cancer	7.23e-05	0.000206	CcSEcCtD
Famotidine—Shock—Epirubicin—breast cancer	7.19e-05	0.000205	CcSEcCtD
Famotidine—Convulsion—Doxorubicin—breast cancer	7.18e-05	0.000204	CcSEcCtD
Famotidine—Diarrhoea—Capecitabine—breast cancer	7.18e-05	0.000204	CcSEcCtD
Famotidine—Dizziness—Docetaxel—breast cancer	7.17e-05	0.000204	CcSEcCtD
Famotidine—Thrombocytopenia—Epirubicin—breast cancer	7.16e-05	0.000204	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Methotrexate—breast cancer	7.12e-05	0.000203	CcSEcCtD
Famotidine—Insomnia—Methotrexate—breast cancer	7.06e-05	0.000201	CcSEcCtD
Famotidine—Chest pain—Doxorubicin—breast cancer	7.06e-05	0.000201	CcSEcCtD
Famotidine—Myalgia—Doxorubicin—breast cancer	7.06e-05	0.000201	CcSEcCtD
Famotidine—Arthralgia—Doxorubicin—breast cancer	7.06e-05	0.000201	CcSEcCtD
Famotidine—Anxiety—Doxorubicin—breast cancer	7.03e-05	0.0002	CcSEcCtD
Famotidine—Paraesthesia—Methotrexate—breast cancer	7.01e-05	0.0002	CcSEcCtD
Famotidine—Anorexia—Epirubicin—breast cancer	6.97e-05	0.000198	CcSEcCtD
Famotidine—Somnolence—Methotrexate—breast cancer	6.94e-05	0.000198	CcSEcCtD
Famotidine—Dizziness—Capecitabine—breast cancer	6.94e-05	0.000197	CcSEcCtD
Famotidine—Dry mouth—Doxorubicin—breast cancer	6.9e-05	0.000196	CcSEcCtD
Famotidine—Vomiting—Docetaxel—breast cancer	6.89e-05	0.000196	CcSEcCtD
Famotidine—Dyspepsia—Methotrexate—breast cancer	6.88e-05	0.000196	CcSEcCtD
Famotidine—Rash—Docetaxel—breast cancer	6.83e-05	0.000194	CcSEcCtD
Famotidine—Dermatitis—Docetaxel—breast cancer	6.83e-05	0.000194	CcSEcCtD
Famotidine—Confusional state—Doxorubicin—breast cancer	6.82e-05	0.000194	CcSEcCtD
Famotidine—Decreased appetite—Methotrexate—breast cancer	6.79e-05	0.000193	CcSEcCtD
Famotidine—Headache—Docetaxel—breast cancer	6.79e-05	0.000193	CcSEcCtD
Famotidine—Anaphylactic shock—Doxorubicin—breast cancer	6.76e-05	0.000193	CcSEcCtD
Famotidine—Oedema—Doxorubicin—breast cancer	6.76e-05	0.000193	CcSEcCtD
Famotidine—Fatigue—Methotrexate—breast cancer	6.73e-05	0.000192	CcSEcCtD
Famotidine—Infection—Doxorubicin—breast cancer	6.72e-05	0.000191	CcSEcCtD
Famotidine—Pain—Methotrexate—breast cancer	6.68e-05	0.00019	CcSEcCtD
Famotidine—Vomiting—Capecitabine—breast cancer	6.67e-05	0.00019	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Epirubicin—breast cancer	6.66e-05	0.00019	CcSEcCtD
Famotidine—Shock—Doxorubicin—breast cancer	6.65e-05	0.000189	CcSEcCtD
Famotidine—Thrombocytopenia—Doxorubicin—breast cancer	6.62e-05	0.000188	CcSEcCtD
Famotidine—Rash—Capecitabine—breast cancer	6.62e-05	0.000188	CcSEcCtD
Famotidine—Insomnia—Epirubicin—breast cancer	6.61e-05	0.000188	CcSEcCtD
Famotidine—Dermatitis—Capecitabine—breast cancer	6.61e-05	0.000188	CcSEcCtD
Famotidine—Headache—Capecitabine—breast cancer	6.57e-05	0.000187	CcSEcCtD
Famotidine—Paraesthesia—Epirubicin—breast cancer	6.56e-05	0.000187	CcSEcCtD
Famotidine—Somnolence—Epirubicin—breast cancer	6.5e-05	0.000185	CcSEcCtD
Famotidine—Anorexia—Doxorubicin—breast cancer	6.45e-05	0.000184	CcSEcCtD
Famotidine—Nausea—Docetaxel—breast cancer	6.44e-05	0.000183	CcSEcCtD
Famotidine—Feeling abnormal—Methotrexate—breast cancer	6.44e-05	0.000183	CcSEcCtD
Famotidine—Dyspepsia—Epirubicin—breast cancer	6.43e-05	0.000183	CcSEcCtD
Famotidine—Gastrointestinal pain—Methotrexate—breast cancer	6.39e-05	0.000182	CcSEcCtD
Famotidine—Decreased appetite—Epirubicin—breast cancer	6.35e-05	0.000181	CcSEcCtD
Famotidine—Fatigue—Epirubicin—breast cancer	6.3e-05	0.000179	CcSEcCtD
Famotidine—Pain—Epirubicin—breast cancer	6.25e-05	0.000178	CcSEcCtD
Famotidine—Constipation—Epirubicin—breast cancer	6.25e-05	0.000178	CcSEcCtD
Famotidine—Nausea—Capecitabine—breast cancer	6.23e-05	0.000177	CcSEcCtD
Famotidine—Urticaria—Methotrexate—breast cancer	6.21e-05	0.000177	CcSEcCtD
Famotidine—Abdominal pain—Methotrexate—breast cancer	6.17e-05	0.000176	CcSEcCtD
Famotidine—Body temperature increased—Methotrexate—breast cancer	6.17e-05	0.000176	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.16e-05	0.000175	CcSEcCtD
Famotidine—Insomnia—Doxorubicin—breast cancer	6.12e-05	0.000174	CcSEcCtD
Famotidine—Paraesthesia—Doxorubicin—breast cancer	6.07e-05	0.000173	CcSEcCtD
Famotidine—Feeling abnormal—Epirubicin—breast cancer	6.02e-05	0.000171	CcSEcCtD
Famotidine—Somnolence—Doxorubicin—breast cancer	6.01e-05	0.000171	CcSEcCtD
Famotidine—Gastrointestinal pain—Epirubicin—breast cancer	5.98e-05	0.00017	CcSEcCtD
Famotidine—Dyspepsia—Doxorubicin—breast cancer	5.95e-05	0.000169	CcSEcCtD
Famotidine—Decreased appetite—Doxorubicin—breast cancer	5.88e-05	0.000167	CcSEcCtD
Famotidine—Fatigue—Doxorubicin—breast cancer	5.83e-05	0.000166	CcSEcCtD
Famotidine—Urticaria—Epirubicin—breast cancer	5.81e-05	0.000165	CcSEcCtD
Famotidine—Pain—Doxorubicin—breast cancer	5.78e-05	0.000165	CcSEcCtD
Famotidine—Constipation—Doxorubicin—breast cancer	5.78e-05	0.000165	CcSEcCtD
Famotidine—Body temperature increased—Epirubicin—breast cancer	5.78e-05	0.000164	CcSEcCtD
Famotidine—Abdominal pain—Epirubicin—breast cancer	5.78e-05	0.000164	CcSEcCtD
Famotidine—Hypersensitivity—Methotrexate—breast cancer	5.75e-05	0.000164	CcSEcCtD
Famotidine—Asthenia—Methotrexate—breast cancer	5.6e-05	0.00016	CcSEcCtD
Famotidine—Feeling abnormal—Doxorubicin—breast cancer	5.57e-05	0.000159	CcSEcCtD
Famotidine—Gastrointestinal pain—Doxorubicin—breast cancer	5.53e-05	0.000157	CcSEcCtD
Famotidine—Pruritus—Methotrexate—breast cancer	5.53e-05	0.000157	CcSEcCtD
Famotidine—Hypersensitivity—Epirubicin—breast cancer	5.39e-05	0.000153	CcSEcCtD
Famotidine—Urticaria—Doxorubicin—breast cancer	5.37e-05	0.000153	CcSEcCtD
Famotidine—Abdominal pain—Doxorubicin—breast cancer	5.35e-05	0.000152	CcSEcCtD
Famotidine—Body temperature increased—Doxorubicin—breast cancer	5.35e-05	0.000152	CcSEcCtD
Famotidine—Diarrhoea—Methotrexate—breast cancer	5.34e-05	0.000152	CcSEcCtD
Famotidine—Asthenia—Epirubicin—breast cancer	5.24e-05	0.000149	CcSEcCtD
Famotidine—Pruritus—Epirubicin—breast cancer	5.17e-05	0.000147	CcSEcCtD
Famotidine—Dizziness—Methotrexate—breast cancer	5.17e-05	0.000147	CcSEcCtD
Famotidine—Diarrhoea—Epirubicin—breast cancer	5e-05	0.000142	CcSEcCtD
Famotidine—Hypersensitivity—Doxorubicin—breast cancer	4.98e-05	0.000142	CcSEcCtD
Famotidine—Vomiting—Methotrexate—breast cancer	4.97e-05	0.000141	CcSEcCtD
Famotidine—Rash—Methotrexate—breast cancer	4.93e-05	0.00014	CcSEcCtD
Famotidine—Dermatitis—Methotrexate—breast cancer	4.92e-05	0.00014	CcSEcCtD
Famotidine—Headache—Methotrexate—breast cancer	4.89e-05	0.000139	CcSEcCtD
Famotidine—Asthenia—Doxorubicin—breast cancer	4.85e-05	0.000138	CcSEcCtD
Famotidine—Dizziness—Epirubicin—breast cancer	4.83e-05	0.000138	CcSEcCtD
Famotidine—Pruritus—Doxorubicin—breast cancer	4.79e-05	0.000136	CcSEcCtD
Famotidine—Vomiting—Epirubicin—breast cancer	4.65e-05	0.000132	CcSEcCtD
Famotidine—Nausea—Methotrexate—breast cancer	4.64e-05	0.000132	CcSEcCtD
Famotidine—Diarrhoea—Doxorubicin—breast cancer	4.63e-05	0.000132	CcSEcCtD
Famotidine—Rash—Epirubicin—breast cancer	4.61e-05	0.000131	CcSEcCtD
Famotidine—Dermatitis—Epirubicin—breast cancer	4.6e-05	0.000131	CcSEcCtD
Famotidine—Headache—Epirubicin—breast cancer	4.58e-05	0.00013	CcSEcCtD
Famotidine—Dizziness—Doxorubicin—breast cancer	4.47e-05	0.000127	CcSEcCtD
Famotidine—Nausea—Epirubicin—breast cancer	4.34e-05	0.000124	CcSEcCtD
Famotidine—Vomiting—Doxorubicin—breast cancer	4.3e-05	0.000122	CcSEcCtD
Famotidine—Rash—Doxorubicin—breast cancer	4.26e-05	0.000121	CcSEcCtD
Famotidine—Dermatitis—Doxorubicin—breast cancer	4.26e-05	0.000121	CcSEcCtD
Famotidine—Headache—Doxorubicin—breast cancer	4.24e-05	0.000121	CcSEcCtD
Famotidine—Nausea—Doxorubicin—breast cancer	4.02e-05	0.000114	CcSEcCtD
Famotidine—CYP2C19—Metabolism—SLCO1B1—breast cancer	2.87e-05	0.000278	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HSP90AA1—breast cancer	2.86e-05	0.000278	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOTCH2—breast cancer	2.86e-05	0.000278	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CD—breast cancer	2.84e-05	0.000275	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	2.82e-05	0.000273	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	2.8e-05	0.000272	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MED12—breast cancer	2.8e-05	0.000271	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—DPYD—breast cancer	2.8e-05	0.000271	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRL—breast cancer	2.78e-05	0.00027	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGTR1—breast cancer	2.78e-05	0.00027	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APRT—breast cancer	2.77e-05	0.000269	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALDOA—breast cancer	2.75e-05	0.000267	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADAM10—breast cancer	2.74e-05	0.000266	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STK11—breast cancer	2.74e-05	0.000266	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—breast cancer	2.72e-05	0.000264	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLG—breast cancer	2.71e-05	0.000263	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—breast cancer	2.71e-05	0.000263	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT2—breast cancer	2.68e-05	0.00026	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NCOA3—breast cancer	2.67e-05	0.000259	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGF10—breast cancer	2.67e-05	0.000259	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC2A2—breast cancer	2.65e-05	0.000258	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—HRAS—breast cancer	2.62e-05	0.000254	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ESRRA—breast cancer	2.61e-05	0.000253	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ANGPTL4—breast cancer	2.61e-05	0.000253	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTR—breast cancer	2.6e-05	0.000252	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CPT1A—breast cancer	2.6e-05	0.000252	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCG2—breast cancer	2.6e-05	0.000252	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CD—breast cancer	2.58e-05	0.00025	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PDGFA—breast cancer	2.58e-05	0.00025	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HPGDS—breast cancer	2.55e-05	0.000248	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TGFBR2—breast cancer	2.54e-05	0.000246	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HBA1—breast cancer	2.53e-05	0.000246	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ITPR1—breast cancer	2.5e-05	0.000242	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ERBB4—breast cancer	2.48e-05	0.000241	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP3—breast cancer	2.48e-05	0.000241	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STAT5A—breast cancer	2.48e-05	0.000241	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	2.48e-05	0.00024	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CB—breast cancer	2.47e-05	0.00024	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTT1—breast cancer	2.47e-05	0.00024	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ACHE—breast cancer	2.47e-05	0.00024	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HADHB—breast cancer	2.47e-05	0.00024	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPI—breast cancer	2.47e-05	0.00024	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SMAD4—breast cancer	2.4e-05	0.000233	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1R—breast cancer	2.39e-05	0.000232	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCL8—breast cancer	2.38e-05	0.000231	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.36e-05	0.000229	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALDH7A1—breast cancer	2.36e-05	0.000229	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALDH1A1—breast cancer	2.36e-05	0.000229	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HES1—breast cancer	2.35e-05	0.000228	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP17A1—breast cancer	2.34e-05	0.000227	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NCOR1—breast cancer	2.33e-05	0.000226	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLA2G4A—breast cancer	2.33e-05	0.000226	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.33e-05	0.000226	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ENO1—breast cancer	2.32e-05	0.000225	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS1—breast cancer	2.32e-05	0.000225	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGF1—breast cancer	2.31e-05	0.000224	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CSF2—breast cancer	2.31e-05	0.000224	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RAF1—breast cancer	2.3e-05	0.000223	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NRG1—breast cancer	2.29e-05	0.000222	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—H2AFX—breast cancer	2.27e-05	0.000221	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2D6—breast cancer	2.27e-05	0.000221	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—IL2—breast cancer	2.27e-05	0.000221	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—UMPS—breast cancer	2.26e-05	0.000219	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NME1—breast cancer	2.26e-05	0.000219	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADSL—breast cancer	2.26e-05	0.000219	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PHGDH—breast cancer	2.26e-05	0.000219	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FHL2—breast cancer	2.26e-05	0.000219	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—E2F1—breast cancer	2.26e-05	0.000219	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CB—breast cancer	2.25e-05	0.000218	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NCOA2—breast cancer	2.23e-05	0.000217	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LDHB—breast cancer	2.22e-05	0.000215	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—BRIP1—breast cancer	2.22e-05	0.000215	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HPSE—breast cancer	2.22e-05	0.000215	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SPP1—breast cancer	2.17e-05	0.00021	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ALB—breast cancer	2.17e-05	0.00021	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—FASN—breast cancer	2.16e-05	0.00021	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCL8—breast cancer	2.16e-05	0.00021	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—BCHE—breast cancer	2.16e-05	0.000209	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ERBB3—breast cancer	2.15e-05	0.000208	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGFR2—breast cancer	2.14e-05	0.000208	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC5A5—breast cancer	2.13e-05	0.000207	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCC1—breast cancer	2.1e-05	0.000204	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA3—breast cancer	2.1e-05	0.000204	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMMR—breast cancer	2.1e-05	0.000204	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL2—breast cancer	2.06e-05	0.0002	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TERT—breast cancer	2.06e-05	0.0002	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC2A1—breast cancer	2.06e-05	0.0002	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NQO1—breast cancer	2.06e-05	0.0002	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARGC1B—breast cancer	2.03e-05	0.000197	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—HRAS—breast cancer	2.01e-05	0.000195	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP3A4—breast cancer	2e-05	0.000195	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGFR1—breast cancer	2e-05	0.000194	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.98e-05	0.000192	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.98e-05	0.000192	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP1B1—breast cancer	1.97e-05	0.000191	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HIF1A—breast cancer	1.97e-05	0.000191	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—RAF1—breast cancer	1.96e-05	0.00019	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HSP90AA1—breast cancer	1.93e-05	0.000188	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA4—breast cancer	1.92e-05	0.000186	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CA9—breast cancer	1.92e-05	0.000186	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LEP—breast cancer	1.92e-05	0.000186	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CAV1—breast cancer	1.9e-05	0.000185	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.9e-05	0.000184	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KDR—breast cancer	1.88e-05	0.000182	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NCOA1—breast cancer	1.88e-05	0.000182	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.88e-05	0.000182	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA2—breast cancer	1.87e-05	0.000182	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPX2—breast cancer	1.87e-05	0.000182	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—STK11—breast cancer	1.85e-05	0.00018	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP19A1—breast cancer	1.85e-05	0.00018	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPX4—breast cancer	1.85e-05	0.000179	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SULT1A1—breast cancer	1.85e-05	0.000179	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ESR1—breast cancer	1.83e-05	0.000178	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FN1—breast cancer	1.81e-05	0.000176	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA1—breast cancer	1.81e-05	0.000175	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—IDH1—breast cancer	1.81e-05	0.000175	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NFKBIA—breast cancer	1.79e-05	0.000174	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NAT2—breast cancer	1.79e-05	0.000173	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOTCH1—breast cancer	1.77e-05	0.000172	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APC—breast cancer	1.73e-05	0.000168	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KIT—breast cancer	1.73e-05	0.000168	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CG—breast cancer	1.73e-05	0.000168	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—COMT—breast cancer	1.72e-05	0.000167	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTP1—breast cancer	1.71e-05	0.000166	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGF—breast cancer	1.71e-05	0.000166	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMOX1—breast cancer	1.69e-05	0.000164	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ITPR1—breast cancer	1.69e-05	0.000164	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MAPK3—breast cancer	1.66e-05	0.000161	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BRAF—breast cancer	1.63e-05	0.000158	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCB1—breast cancer	1.62e-05	0.000158	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.61e-05	0.000157	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TYMS—breast cancer	1.59e-05	0.000155	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1—breast cancer	1.59e-05	0.000154	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT2—breast cancer	1.58e-05	0.000154	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EGFR—breast cancer	1.58e-05	0.000153	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTM1—breast cancer	1.58e-05	0.000153	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NCOR1—breast cancer	1.58e-05	0.000153	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLA2G4A—breast cancer	1.58e-05	0.000153	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MED12—breast cancer	1.57e-05	0.000152	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—DPYD—breast cancer	1.57e-05	0.000152	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALDOA—breast cancer	1.54e-05	0.00015	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CD—breast cancer	1.52e-05	0.000148	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GPX1—breast cancer	1.51e-05	0.000146	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CA—breast cancer	1.51e-05	0.000146	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SERPINE1—breast cancer	1.51e-05	0.000146	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NCOA3—breast cancer	1.5e-05	0.000145	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP1A1—breast cancer	1.49e-05	0.000145	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—KRAS—breast cancer	1.49e-05	0.000145	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC2A2—breast cancer	1.49e-05	0.000144	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ERCC2—breast cancer	1.48e-05	0.000144	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.47e-05	0.000143	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTR—breast cancer	1.46e-05	0.000141	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CPT1A—breast cancer	1.46e-05	0.000141	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCG2—breast cancer	1.46e-05	0.000141	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOS3—breast cancer	1.44e-05	0.00014	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HPGDS—breast cancer	1.43e-05	0.000139	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HBA1—breast cancer	1.42e-05	0.000138	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTHFR—breast cancer	1.39e-05	0.000135	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTT1—breast cancer	1.38e-05	0.000134	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ACHE—breast cancer	1.38e-05	0.000134	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CA—breast cancer	1.37e-05	0.000133	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MDM2—breast cancer	1.36e-05	0.000132	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RAF1—breast cancer	1.36e-05	0.000132	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RELA—breast cancer	1.35e-05	0.000131	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ERBB2—breast cancer	1.34e-05	0.000131	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CB—breast cancer	1.33e-05	0.000129	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MTOR—breast cancer	1.33e-05	0.000129	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP17A1—breast cancer	1.31e-05	0.000127	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS1—breast cancer	1.3e-05	0.000126	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ENO1—breast cancer	1.3e-05	0.000126	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.29e-05	0.000125	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAV1—breast cancer	1.28e-05	0.000125	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.28e-05	0.000124	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCL8—breast cancer	1.28e-05	0.000124	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2D6—breast cancer	1.27e-05	0.000123	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HRAS—breast cancer	1.27e-05	0.000123	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NCOA2—breast cancer	1.25e-05	0.000121	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN1B—breast cancer	1.25e-05	0.000121	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—breast cancer	1.23e-05	0.00012	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASP3—breast cancer	1.22e-05	0.000118	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL2—breast cancer	1.22e-05	0.000118	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—breast cancer	1.21e-05	0.000118	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FASN—breast cancer	1.21e-05	0.000118	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—BCHE—breast cancer	1.21e-05	0.000117	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC5A5—breast cancer	1.19e-05	0.000116	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCND1—breast cancer	1.19e-05	0.000115	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—JUN—breast cancer	1.19e-05	0.000115	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CTNNB1—breast cancer	1.18e-05	0.000114	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CG—breast cancer	1.17e-05	0.000114	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—breast cancer	1.15e-05	0.000112	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC2A1—breast cancer	1.15e-05	0.000112	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NQO1—breast cancer	1.15e-05	0.000112	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN1A—breast cancer	1.15e-05	0.000112	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTEN—breast cancer	1.15e-05	0.000111	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.13e-05	0.000109	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP3A4—breast cancer	1.12e-05	0.000109	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK8—breast cancer	1.12e-05	0.000109	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—breast cancer	1.12e-05	0.000109	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.12e-05	0.000108	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP1B1—breast cancer	1.1e-05	0.000107	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HSP90AA1—breast cancer	1.08e-05	0.000105	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SRC—breast cancer	1.06e-05	0.000103	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NCOA1—breast cancer	1.05e-05	0.000102	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—STK11—breast cancer	1.04e-05	0.000101	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP19A1—breast cancer	1.04e-05	0.000101	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—breast cancer	1.04e-05	0.000101	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CD—breast cancer	1.03e-05	9.98e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STAT3—breast cancer	1.03e-05	9.95e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALB—breast cancer	1.02e-05	9.85e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK3—breast cancer	9.8e-06	9.51e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	9.74e-06	9.45e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NOS3—breast cancer	9.71e-06	9.43e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—COMT—breast cancer	9.64e-06	9.36e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTP1—breast cancer	9.6e-06	9.31e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MYC—breast cancer	9.53e-06	9.25e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TGFB1—breast cancer	9.51e-06	9.23e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMOX1—breast cancer	9.47e-06	9.19e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ITPR1—breast cancer	9.44e-06	9.16e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGFR—breast cancer	9.32e-06	9.05e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCB1—breast cancer	9.08e-06	8.82e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CB—breast cancer	8.97e-06	8.7e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TYMS—breast cancer	8.92e-06	8.66e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—breast cancer	8.88e-06	8.62e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLA2G4A—breast cancer	8.82e-06	8.56e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NCOR1—breast cancer	8.82e-06	8.56e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTM1—breast cancer	8.82e-06	8.56e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KRAS—breast cancer	8.81e-06	8.55e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPX1—breast cancer	8.45e-06	8.2e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP1A1—breast cancer	8.36e-06	8.11e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ERCC2—breast cancer	8.29e-06	8.05e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CA—breast cancer	8.09e-06	7.85e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TP53—breast cancer	7.83e-06	7.6e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTHFR—breast cancer	7.79e-06	7.56e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTEN—breast cancer	7.75e-06	7.52e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HRAS—breast cancer	7.49e-06	7.26e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAV1—breast cancer	7.19e-06	6.98e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—breast cancer	7.16e-06	6.95e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.87e-06	6.67e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—breast cancer	6.61e-06	6.41e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CG—breast cancer	6.55e-06	6.36e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CD—breast cancer	5.76e-06	5.59e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALB—breast cancer	5.68e-06	5.52e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CA—breast cancer	5.47e-06	5.3e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NOS3—breast cancer	5.44e-06	5.28e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CB—breast cancer	5.02e-06	4.87e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—breast cancer	4.97e-06	4.83e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—breast cancer	4.46e-06	4.33e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTEN—breast cancer	4.34e-06	4.21e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CA—breast cancer	3.06e-06	2.97e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—breast cancer	2.5e-06	2.43e-05	CbGpPWpGaD
